Cancer cell., Tập 24, Số 1, 2013
Mục lục:
DòngNội dung
1BRAF: A Driver of the Serrated Pathway in Colon Cancer / Anil K. Rustgi
2Par(−4)oxysm in Breast Cancer / Tripti Shrestha-Bhattarai, Nikhil Hebbar,Vivek M. Rangnekar
3Linking MLL Leukemia with Integrin Signaling / Bernd B. Zeisig, Chi Wai Eric So
4BCL-2: A New Therapeutic Target in Estrogen Receptor-Positive Breast Cancer? / Lesley-Ann Martin, Mitch Dowsett
5Platelets and Tumor Cells: A New Form of Border Control / Ben Z. Stanger, Mark L. Kahn
6GEMMs Shine a Light on Resistance to Androgen Deprivation Therapy for Prostate Cancer
7A Genetic Progression Model of BrafV600E-Induced Intestinal Tumorigenesis Reveals Targets for Therapeutic Intervention / Roland Rad and others
8In Vivo RNAi Screening Identifies a Leukemia-Specific Dependence on Integrin Beta 3 Signaling / Peter G. Miller and others
9Par-4 Downregulation Promotes Breast Cancer Recurrence by Preventing Multinucleation following Targeted Therapy / James V. Alvarez and others
10A Rare Population of CD24+ITGB4+Notchhi Cells Drives Tumor Propagation in NSCLC and Requires Notch3 for Self-Renewal / Yanyan Zheng and others
11Small Molecule Inhibitors of Aurora-A Induce Proteasomal Degradation of N-Myc in Childhood Neuroblastoma / Markus Brockmann and others
12Targeting IRAK1 as a Therapeutic Approach for Myelodysplastic Syndrome / Garrett W. Rhyasen and others
13Directed Phenotype Switching as an Effective Antimelanoma Strategy / Magalı Saez-Ayala and others
14Targeting BCL-2 with the BH3 Mimetic ABT-199 in Estrogen Receptor-Positive Breast Cancer / Francois Vaillant and others
15Platelet-Derived Nucleotides Promote Tumor-Cell Transendothelial Migration and Metastasis via P2Y2 Receptor / Dagmar Schumacher, Boris Strilic, Kishor Kumar Sivaraj